Atrium is a biopharmaceutical company pioneering delivery of RNA therapeutics to the heart to transform the standard of care for people living with cardiomyopathies. Our proprietary technology leverages the targeted RNA delivery platform initially designed at Avidity, which combines the tissue selectivity of mAbs and other targeted delivery ligands with the precision of oligonucleotides. This unique combination is designed to allow selective targeting of the underlying genetic drivers of disease that were previously undruggable. Through targeted, non-viral delivery of siRNA to cardiac tissues, our approach has the potential to overcome key limitations of nonspecific viral and nanoparticle-based delivery systems, including challenges related to tissue specificity, immunogenicity, and redosing. Job Summary: The Senior Director/Director of AOC Analytical Development & Quality Control will lead analytical strategy and quality control activities for oligonucleotide, monoclonal antibody (mAb), AOC drug substance and product across all development phases. This role is responsible for establishing robust analytical methods, ensuring compliance with regulatory requirements, and supporting CMC activities from early development through commercialization. The ideal candidate will have deep expertise in analytical method development and validation, stability programs, and experience managing teams and external partners.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director